1Neuhofer W, Pittrow D. Role of endothelin and endothelin receptor antagonists in renal disease. Eur J Clin Invest, 2006 ; 36 ( Surppl 3) : 78 - 88.
2Hargrove GM, Dufresne J, Whiteside C et al. Diabetes mellitus increases endothelin - 1 gene transcription in rat kidney. Kidney Int, 2000; 58 (4): 1534-1545.
3Lopez - Ongil S, Diez - Marques ML, Griera M et al. Crosstalk between mesangial and endothelial cells: angiotensin Ⅱ down - regulates endothelin - converting enzyme 1. Cell Physiol Biochem, 2005; 15 (1-4): 135-144.
4Kuo HT, Shin SJ, Kuo MC et al. Effects of specific endothelin - 1 receptor antagonists on proliferation and fibronectin production of glomerular mesangial cells stimulated with Angiotensin Ⅱ. Kaohsiung J Med Sci, 2006; 22 (8) : 371 - 376.
5Itoh Y, Nakai A, Kakizawa Het al. Alteration of endothel in - 1 concentration in STZ - induced diabetic rat nephropathy. Effects of a PGI (2) derivative. Horm Res, 2001; 56 (5-6): 165-171.
6Chen HC, Guh JY, Shin SJ et al. Reactive oxygen species enhances endothelin - 1 production of diabetic rat glomeruli in vitro and in vivo. J Lab Clin Med, 2000; 135 (4) : 300 - 302.
7Ak G, Buyukberber S, Sevinc Aet al. The relation between plasma endothelin - 1 levels and metabolic control, risk fators, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. J Diabetes Complications, 2001; 15 (3): 150-157.
8Bruno CM, Meli S, Marcinno M et al. Plasma endothelin - 1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients. J Biol Regul Homeost Agents, 2002; 16 (2): 114-117.
3Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity onset diabetes. N Engl J Med, 1984,310: 356-360.
4Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997;29(1):2-26.
5Sugimoto K, Tsuruoka S, Fujimura A. Renal protective effect of YM598, a selective endothelin ET (A) receptor antagonist, against diabetic nephropathy in OLETF rats. Eur J Pharmacol 2002;450(2):183-189.
6Dhein S, Hochreuther S, Aus Dem Spring C, et al. Long-term effects of the endothelin(A) receptor antagonist LU135252 and the angiotensin-converting enzyme inhibitor trandolaprll on diabetic angiopathy and nephropathy in a chronic type 1 diabetes mellitus rat model. J Pharmacol Exp Ther 2000; 293 (2) :351-359.
